CHC Healthcare Group (TPE:4164)

Market Cap	7.49B
Revenue (ttm)	3.95B
Net Income (ttm)	174.52M
Shares Out	170.68M
EPS (ttm)	1.01
PE Ratio	43.44
Forward PE	21.47
Dividend	1.51 (3.44%)
Ex-Dividend Date	Jun 26, 2025

Volume	634,327
Average Volume	3,468,109
Open	44.10
Previous Close	43.90
Day's Range	43.15 - 44.85
52-Week Range	35.50 - 60.40
Beta	0.31
RSI	39.45
Earnings Date	Aug 13, 2025

About CHC Healthcare Group

CHC Healthcare Group, together with its subsidiaries, engages in trading of pharmaceutical products and health food in Taiwan, China, and internationally. The company is also involved in the sale, leasing, installing, and repairing of medical instruments. In addition, it engages in the sale of ophthalmic equipment; irradiation business; sale of drug and health supplements; consulting, elderly residence, and senior fitness services; Long-term care services; and leasing of veterinary medical instruments. CHC Healthcare Group was founded in 1977 a...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1977
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 4164

Financial Performance

In 2024, CHC Healthcare Group's revenue was 3.60 billion, a decrease of -7.13% compared to the previous year's 3.88 billion. Earnings were 168.38 million, a decrease of -59.80%.